Fovea ERM After Fovea-sparing ILM Peeling

To report cases who had received previous fovea-sparing internal limiting peeling membrane and developed secondary fovea epiretinal membrane contraction

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Epiretinal Membrane Eye Diseases Internal Limiting Membrane Wrinkling Retinal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of ophthalmology, Changhua Christian Hospital

Changhua, 500, Taiwan

About this study

Purpose: To report the rare complication of foveal epiretinal membrane (ERM) formation on residual internal limiting membrane (ILM) with severe contraction after previous fovea-sparing internal limiting membrane (ILM) peeling.

Study design: Retrospective case series Methods: We report patients who previously received fovea-sparing ILM peeling and complicated with foveal ERM formation and contraction.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients who developed secondary fovea epiretinal membrane after previous fovea-sparing internal limiting membrane surgery

Exclusion criteria

patients who did not receive previous fovea-sparing internal limiting membrane surgery

Treatment and study plan

fovea-sparing internal limiting membrane peeling

Procedure

fovea-sparing internal limiting membrane peeling surgery

Primary outcomes

Visual acuity

Time frame: 6 months

Snellen visual acuity change
Optical coherence tomography finding

Time frame: 6 months

fovea change on optical coherence tomography

Sponsors and collaborators

Lead sponsor

Changhua Christian Hospital

Other

Registry information

Official study title

Severe Foveal Epiretinal Membrane Contraction After Previous Fovea-sparing Internal Limiting Membrane Peeling Surgery

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Jun 24, 2020
Registry last updated: Jun 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed